Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

63.47
+3.565.94%
Post-market: 63.940.4700+0.74%19:44 EDT
Volume:640.79K
Turnover:40.08M
Market Cap:1.81B
PE:162.74
High:64.00
Open:59.76
Low:59.76
Close:59.91
52wk High:64.00
52wk Low:14.27
Shares:28.58M
Float Shares:26.68M
Volume Ratio:0.56
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:38.94
PE(LYR):-371.19

Loading ...

Eton Pharma names Judy Matthews CFO, succeeding James Gruber

Reuters
·
Apr 16

Eton Pharmaceuticals Inc - Appoints Judith M. Matthews as CFO Effective June 1, 2026

THOMSON REUTERS
·
Apr 16

Eton Pharmaceuticals Inc - James Gruber to Step Down as CFO Effective May 31, 2026

THOMSON REUTERS
·
Apr 16

Press Release: Eton Pharmaceuticals Announces CFO Succession Plan

Dow Jones
·
Apr 16

Eton Pharma amends SWK credit agreement, cuts interest rate to SOFR+6.55%

Reuters
·
Apr 16

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Mar 21

Eton Pharmaceuticals price target raised to $35 from $30 at Craig-Hallum

TIPRANKS
·
Mar 20

B. Riley Raises Price Target on Eton Pharmaceuticals to $31 From $26, Keeps Buy Rating

MT Newswires Live
·
Mar 20

U.S. RESEARCH ROUNDUP-Air Products, Chevron, FedEx

Reuters
·
Mar 20

Eton Pharma Q4 product sales rise 83% to USD 21.3 million, adjusted gross profit more than doubled to USD 15.5 million

Reuters
·
Mar 20

BRIEF-Eton Pharmaceuticals Q4 Net Income USD 1.483 Million

Reuters
·
Mar 20

Eton Pharmaceuticals Q4 EPS USD 0.05

THOMSON REUTERS
·
Mar 20

Eton Pharmaceuticals Inc - Expects FY2026 Revenue to Exceed $110 Mln, Adj Ebitda Margin Over 30%

THOMSON REUTERS
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 16

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

Eton Pharmaceuticals Inc. to Report Fourth-Quarter and Full-Year Financial Results and Host Conference Call

Reuters
·
Mar 04

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
Mar 03

Eton Pharmaceuticals Rises on Acquisition of Hemangeol U.S. Commercialization Rights

Dow Jones
·
Mar 03

Analysts Conflicted on These Healthcare Names: Denali Therapeutics (DNLI), Eton Pharmaceuticals (ETON) and Intellia Therapeutics (NTLA)

TIPRANKS
·
Mar 02